Designed for execution

In vivo studies may be easy to design. Execution determines their value.


Preclinical studies fail when designs don’t match operational reality.

NeuroVivo brings 20+ years of hands-on in vivo execution to pressure-test study plans, validate AI-generated designs, and support CRO execution for reliable, on-time data.

Ready to reduce execution risk before your next study?

Ensure your preclinical plan is feasible, executable, and ready before engaging CROs or committing significant resources.

When to engage Neurovivo

NeuroVivo is engaged to complement scientific leadership with hands-on in vivo execution expertise, ensuring study plans translate smoothly into reliable outcomes.

Before CRO selection or study initiation

When a study concept or protocol is defined and sponsors want confidence that execution, timelines, and resource assumptions are aligned before engaging CROs.

When bringing design into execution

When well-designed in vivo studies are moving into execution and hands-on expertise can help streamline workflows, anticipate operational nuances, and maintain data consistency.

When leveraging AI-generated or standardized designs

When AI-generated or templated study designs are used and benefit from expert pressure-testing against real-world in vivo execution conditions.

When execution oversight benefits from independent perspective

When sponsors value an independent, hands-on execution perspective to support CRO interactions, align expectations, and keep studies on track.

Why NeuroVivo?


NeuroVivo brings over 20 years of hands-on in vivo expertise to help sponsors and research teams navigate complex preclinical studies with clarity and confidence.

Hands-On Expertise

Practical, real-world guidance rooted in 20+ years of surgical, behavioral, and preclinical in vivo experience.

Tailored Operational Support

Customized recommendations and onsite troubleshooting to strengthen techniques, workflows, and study execution.

Strategic Research Alignment

CRO selection, AI-design feasibility checks, and data auditing to ensure your studies are robust, feasible, and acquisition-ready.

Services

AI-Generated Study Designs Feasibility

  • Identify execution risks in AI-drafted studies
  • Align proposed designs with real-world constraints

GEM Sourcing & Animal Model Selection

  • Source animal models suited to your goals
  • Confirm biological and operational model fit

Technique Setup & Refinement

  • Optimize procedures for clean, reproducible data
  • Resolve execution issues during studies

Study Troubleshooting

  • Diagnose root causes of study failures
  • Implement corrective actions to recover outcomes

Sponsor-CRO liaison

  • Select CROs aligned with your study needs
  • Monitor execution to prevent costly deviations

Data Auditing & Acquisition Readiness

  • Verify data quality before interpretation
  • Identify analytical gaps affecting conclusion

About Neurovivo

Clara Tourino, PhD

Translational Neuroscience & In Vivo Strategy Consultant

With over 25 years of hands-on experience in preclinical in vivo research, Clara founded NeuroVivo LLC to help institutions navigate the technical, operational, and regulatory complexities of in vivo studies

Hsing-Chen Tsai, PhD 

Cell & Gene Therapy Development Consultant

Hsing-Chen

Dr. Hsing-Chen Tsai brings over 20 years of experience in neuroscience, gene therapy, and translational pharmacology to NeuroVivo’s consulting team.

Gloria Mas Martin, PhD

Translational Oncology Consultant

Dr. Gloria Mas Martin is a translational research leader with over 15 years of experience integrating in vivo models with multi-omic biomarker discovery to inform therapeutic strategy.

Contact


We partner with biotech teams to strengthen study designs, validate AI‑generated plans, and ensure operational feasibility before execution.
Reach out to discuss your program or request a consultation.